Dr. Adam Wollowick

Qualifications: MD, MBA

Joined Kuros in 2026

Adam Wollowick is an experienced executive, advisor and surgeon. From 2014 to 2026, he served as Sr. Director of Business Development at Stryker, with a focus on mergers and acquisitions. His tenure at Stryker included support for Spine, Spine Enabling Technologies, Neurotechnology, and Trauma & Extremities. During his time at Spine, he also had responsibility for the Spine Division’s Strategy and Market Intelligence functions.

From 2007-2014, Adam worked as an attending surgeon in the Department of Orthopaedic Surgery at Montefiore Medical Center, Bronx, New York and specialized in adult and pediatric spine surgery. He held the title of Assistant Professor of Orthopaedic Surgery at the Albert Einstein College of Medicine, Bronx, New York. Adam is board-­certified by the American Board of Orthopaedic Surgery. His award-winning research has been presented nationally and internationally at major orthopedic and spine society meetings and has been published in peer-reviewed journals.

Adam advises MedTech startups through Precision Life Science Partners, has served as a mentor at Endless Frontier Labs, and sits on the advisory boards of Matricelf and Regerna Therapeutics.

Adam graduated Cum Laude from Dartmouth College in 1996. He received his MD in 2001 with Special Distinction in Research from the Albert Einstein College of Medicine, Bronx, New York. He completed an MBA in 2014 from the Yale School of Management, with a focus on Leadership in Healthcare Management.